Objective Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether ...

The Post-Bariatric Hypoglycemia market growth is driven by factors like increase in the prevalence of Post-Bariatric ...

Reports of fluoroquinolone-induced hypoglycemia are abundant, but reports of hyperglycemia induced by fluoroquinolones are also available. [15–19] The primary theory of fluoroquinolone ...

Hypoglycemia is described as blood sugar levels below 70 milligrams per deciliter. It's most commonly seen in people with diabetes, especially type 1 diabetes. Low glucose symptoms include ...

Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe ...

Hypoglycemia (low blood sugar) is not a formal symptom of lupus, but it may develop from related factors like medication use, other autoimmune processes in the body, and hormonal changes.

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...

Glytec increased its customer base and overall healthcare impact significantly, driven by a combination of over 20 new and expanded client accounts. Across these new and ...